BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19235922)

  • 21. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer.
    Sugimoto T; Arai M; Shimada H; Hata A; Seki N
    Oncol Rep; 2007 Aug; 18(2):465-72. PubMed ID: 17611672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization.
    Weber-Hall S; Anderson J; McManus A; Abe S; Nojima T; Pinkerton R; Pritchard-Jones K; Shipley J
    Cancer Res; 1996 Jul; 56(14):3220-4. PubMed ID: 8764111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer.
    Dehan E; Ben-Dor A; Liao W; Lipson D; Frimer H; Rienstein S; Simansky D; Krupsky M; Yaron P; Friedman E; Rechavi G; Perlman M; Aviram-Goldring A; Izraeli S; Bittner M; Yakhini Z; Kaminski N
    Lung Cancer; 2007 May; 56(2):175-84. PubMed ID: 17258348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel genes, possibly relevant for molecular diagnosis or therapy of human rhabdomyosarcoma, detected by genomic expression profiling.
    Bortoluzzi S; Bisognin A; Romualdi C; Danieli GA
    Gene; 2005 Mar; 348():65-71. PubMed ID: 15777710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
    Huang J; Sheng HH; Shen T; Hu YJ; Xiao HS; Zhang Q; Zhang QH; Han ZG
    FEBS Lett; 2006 Jun; 580(15):3571-81. PubMed ID: 16750200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
    Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
    Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
    Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
    Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA copy number variation and gene expression analyses reveal the implication of specific oncogenes and genes in GBM.
    Margareto J; Leis O; Larrarte E; Pomposo IC; Garibi JM; Lafuente JV
    Cancer Invest; 2009 Jun; 27(5):541-8. PubMed ID: 19219654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal imbalances revealed in primary rhabdomyo-sarcomas by comparative genomic hybridization.
    Li QX; Liu CX; Chun CP; Qi Y; Chang B; Li XX; Chen YZ; Nong WX; Li HA; Li F
    Chin Med J (Engl); 2009 Jun; 122(11):1277-82. PubMed ID: 19567137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.
    Toffolatti L; Frascella E; Ninfo V; Gambini C; Forni M; Carli M; Rosolen A
    J Pathol; 2002 Apr; 196(4):450-8. PubMed ID: 11920742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.